Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

First Report of a Human Isolate ofErwinia persicinus

Caroline M. O’Hara, Arnold G. Steigerwalt, Bertha C. Hill, J. Michael Miller, Don J. Brenner
Caroline M. O’Hara
Nosocomial Pathogens Laboratory Branch, Hospital Infections Program, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnold G. Steigerwalt
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Center for Disease Control and Prevention, Atlanta, Georgia 30333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertha C. Hill
Nosocomial Pathogens Laboratory Branch, Hospital Infections Program, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Michael Miller
Nosocomial Pathogens Laboratory Branch, Hospital Infections Program, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don J. Brenner
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Center for Disease Control and Prevention, Atlanta, Georgia 30333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.36.1.248-250.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Erwinia persicinus was first described in 1990 after being isolated from a variety of fruits and vegetables, including bananas, cucumbers, and tomatoes. In 1994, it was shown to be the causative agent of necrosis of bean pods. We now report the first human isolate of E. persicinus. The strain was isolated from the urine of an 88-year-old woman who presented with a urinary tract infection. By the hydroxyapatite method, DNA from this strain was shown to be 94.5% related at 60°C and 86% related at 75°C to the type strain of E. persicinus. The biochemical profile ofE. persicinus is most similar to those of Erwinia rhapontici, Pantoea agglomerans, andEnterobacter species. It is negative in tests for lysine, arginine, ornithine, dulcitol, and urea. It is motile and positive in tests for d-sorbitol and sucrose. It is susceptible to the expanded-spectrum cephalosporins, aminoglycosides, and fluoroquinolones, but it is resistant to ampicillin, ticarcillin, and cefazolin.

Erwinia persicinus is a plant pathogen that was described by Hao et al. (6) in 1990. These first five strains were isolated from tomatoes (n= 3), cucumber (n = 1), and banana (n = 1). In 1994, Brenner et al. (3) reported that E. persicinus was a senior subjective synonym for “Erwinia nulandii,” an organism that was pathogenic for bean pods and seeds. There are no reports in the literature of human or animal isolates of E. persicinus.

View this table:
  • View inline
  • View popup
Table 1.

DNA relatedness of E. persicinus strains examined in this study

A computer-based program at the Centers for Disease Control and Prevention aids in the identification of isolates that are submitted from state public health laboratories. When the conventional biochemical reactions for a given isolate are entered into the program, the program searches the database and returns a listing of the 50 most closely related isolates that it contains. When the reactions from this organism were entered, three of the first six strains on the list were the hybridized E. persicinus strains of Hao et al. (6); two were strains, identified in this paper, which had previously been reported as “unidentified.”

In this paper, we report the first human isolate of E. persicinus and an additional food isolate.

Bacterial strains.The strains used in this study are listed in Table 1. All were maintained at −70°C in defibrinated sheep blood. All strains were passed twice on Trypticase soy agar with 5% sheep blood (Becton Dickinson Microbiology Systems, Sparks, Md.) before being used.

Media and biochemicals.The biochemical tests were performed on conventional media by the methods of Ewing (4) and by using some of the modifications described by Farmer et al. (5) and by Hickman and Farmer (7). Incubations were at 35°C, and test results were read at 24 h, 48 h, and 7 days, unless otherwise noted. Commercially available media were used whenever possible.

Antimicrobial susceptibility.Antimicrobial susceptibility profiles were determined for seven strains by the Kirby-Bauer disk diffusion method (8). MICs were determined by using a broth microdilution method and cation-supplemented Mueller-Hinton broth (9).

DNA methods.The preparation, isolation, and purification of labeled and unlabeled DNA, the method used for DNA reassociation, and the method used to separate single-stranded and double-stranded DNAs on hydroxyapatite have been described elsewhere (1, 2). The DNAs were labeled enzymatically in vitro with [32P]dCTP by using a nick-translation reagent kit (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) as directed by the manufacturer.

Results and discussion.Labeled DNA from E. persicinus 9108-82T was shown to be 81 to 100% related (average, 87%) to unlabeled DNA from four other confirmedE. persicinus strains tested in 60°C reactions (Table 1). Divergence within the related sequences averaged 3%, and the degree of relatedness in reactions at 75°C was 76 to 98% (average, 86%).E. persicinus was 62% related to the type strain ofErwinia rhapontici, 50% related to a second E. rhapontici strain, and 49% related to Pantoea agglomerans. The percent divergence to these three strains was 10.0 to 10.5. The degree of relatedness of labeled DNA from E. persicinus 9108-82 to that of the human strain (strain 4073-83) was 95% at 60°C, with 3.5% divergence, and 86% at 75°C. The type strain showed a similar level of relatedness to the strain isolated from tuna (strain 839-82). These relatedness values leave no doubt that the human and tuna strains are E. persicinus.

The biochemical profiles of the two newly identified strains are characteristic of the profiles found for E. persicinusstrains (Table 2). Reactions that differ from those of the type strain include the methyl red, Voges-Proskauer, Simmons citrate, rhamnose, esculin, melibiose, and galactose reactions. Partial differentiation from other Enterobacter species,E. rhapontici, and Pantoea species is presented in Table 3. Accurate identification ofE. persicinus in the clinical laboratory may not be possible without the use of the extended set of conventional biochemicals listed in Table 2. Hao et al. (6) reported that all five strains in their study produced a water-soluble pink pigment when grown on peptone yeast agar supplemented with 1% glucose at 20, 25, and 30°C. Of the seven strains that we studied, strains 9108-82T and 4073-83 produced pigment at 25°C and strain 9109-82 produced pigment at both 25 and 30°C on this same medium.

View this table:
  • View inline
  • View popup
Table 2.

Conventional biochemical reactions for seven strains of E. persicinus

View this table:
  • View inline
  • View popup
Table 3.

Differentiation of E. persicinus andEnterobacter species

Strain 4073-83 was isolated from the urine of an 88-year-old female who presented with a urinary tract infection. The clinical history of the patient was extremely sparse; however, she had a history of atherosclerotic coronary vascular disease with congestive heart failure, hypertension, and diabetes mellitus. Her diagnoses also included a lower leg hematoma and stasis dermatitis. Her medications included indomethacin (Indocin; 25 mg three times daily [t.i.d.]), methyldopa (Aldomet; 250 mg t.i.d.), chlorpropamide (Diabinese; 250 mg daily), dipyridamole (Persantine; 25 mg t.i.d.), digoxin (Lanoxin; 0.25 mg every 3rd day), hydrochlorothiazide-triamterene (Dyazide; twice daily), furosemide (Lasix; 40 mg t.i.d.), phenytoin (Dilantin; t.i.d.), and potassium chloride (Slow K; 600 mg t.i.d.) but included no antimicrobial agents. She had been receiving most of these medications for the previous 18 months. Data regarding the colony count associated with this isolate was unavailable, making its significance in this patient unclear.

Strain 839-82 was isolated from raw tuna in Berlin, Germany. The isolate produced histamine, but it is unknown if this strain was associated with a foodborne disease.

Antimicrobial susceptibility data are shown in Table4. All seven strains are susceptible to all 23 agents tested with the exception of ampicillin, ticarcillin, and cefazolin. The susceptibilities for these last three antimicrobial agents are at the threshold of the intermediate-resistance breakpoint.

View this table:
  • View inline
  • View popup
Table 4.

Antimicrobial susceptibilities of seven strains ofE. persicinus by broth microdilution

Data for E. persicinus are not included in the database of any commercially available identification product. If inoculated into any of these products, the isolate would most likely be identified asP. agglomerans. Such isolates should be examined further to determine whether they are E. persicinus so that the full spectrum of disease associated with this species can be further defined.

FOOTNOTES

    • Received 11 July 1997.
    • Returned for modification 20 August 1997.
    • Accepted 19 September 1997.
  • Copyright © 1998 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Brenner D. J.,
    2. Grimont P. A. D.,
    3. Steigerwalt A. G.,
    4. Fanning G. R.,
    5. Ageron E.,
    6. Riddle C. F.
    Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies.Int. J. Syst. Bacteriol. 43 1993 645 658
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Brenner D. J.,
    2. McWhorter A. C.,
    3. Leete-Knutson J. K.,
    4. Steigerwalt A. G.
    Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds.J. Clin. Microbiol. 15 1982 1133 1140
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Brenner D. J.,
    2. Neto J. R.,
    3. Steigerwalt A. G.,
    4. Robbs C. F.
    “Erwinia nulandii” is a subjective synonym of Erwinia persicinus.Int. J. Syst. Bacteriol. 44 1994 282 284
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ewing W. H.
    Edwards and Ewing’s identification of Enterobacteriaceae 4th ed. 1986 Elsevier New York, N.Y
  5. 5.↵
    1. Farmer J. J. III,
    2. Asbury M. A.,
    3. Hickman F. W.,
    4. Brenner D. J.,
    5. the Enterobacteriaceae Study Group
    Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens.Int. J. Syst. Bacteriol. 30 1980 569 584
    OpenUrlCrossRef
  6. 6.↵
    1. Hao M. V.,
    2. Brenner D. J.,
    3. Steigerwalt A. G.,
    4. Kosako Y.,
    5. Komagata K.
    Erwinia persicinus, a new species isolated from plants.Int. J. Syst. Bacteriol. 40 1990 379 383
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Hickman F. W.,
    2. Farmer J. J.
    Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing.Am. J. Med. Technol. 44 1978 1149 1159
    OpenUrlPubMedWeb of Science
  8. 8.↵
    National Committee for Clinical Laboratory Standards Performance standards for antimicrobic disc susceptibility tests. Approved standard M2-A6. 1997 National Committee for Clinical Laboratory Standards Wayne, Pa
  9. 9.↵
    National Committee for Clinical Laboratory Standards Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. 1997 National Committee for Clinical Laboratory Standards Wayne, Pa
PreviousNext
Back to top
Download PDF
Citation Tools
First Report of a Human Isolate ofErwinia persicinus
Caroline M. O’Hara, Arnold G. Steigerwalt, Bertha C. Hill, J. Michael Miller, Don J. Brenner
Journal of Clinical Microbiology Jan 1998, 36 (1) 248-250; DOI: 10.1128/JCM.36.1.248-250.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
First Report of a Human Isolate ofErwinia persicinus
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
First Report of a Human Isolate ofErwinia persicinus
Caroline M. O’Hara, Arnold G. Steigerwalt, Bertha C. Hill, J. Michael Miller, Don J. Brenner
Journal of Clinical Microbiology Jan 1998, 36 (1) 248-250; DOI: 10.1128/JCM.36.1.248-250.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Erwinia

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X